Location History:
- Katsushika-ku, Tokyo, JP (1991)
- Tokyo, JP (1989 - 1992)
Company Filing History:
2 out of 637 
1 out of 832,680 Years Active: 1989-1992
Title: Kozo Tomatsu: Innovator in Antifungal Antibiotics
Introduction
Kozo Tomatsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of antibiotics, particularly in the development of antifungal and antiviral agents. With a total of 3 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Tomatsu's latest patents include a novel antibiotic designated as BU-3608, along with its variants BU-3608 B and BU-3608 C. These antibiotics are produced through the fermentation of Actinomadura hibisca Strain No. P157-2, ATCC 53557, and Strain No. Q278-4, ATCC 53646. The antibiotics exhibit both antifungal and antiviral activities, showcasing their versatility in combating various infections.
Career Highlights
Throughout his career, Kozo Tomatsu has worked with prominent companies, including Bristol-Myers Company. His experience in the pharmaceutical industry has allowed him to develop innovative solutions to pressing health challenges.
Collaborations
Tomatsu has collaborated with notable colleagues such as Toshikazu Oki and Kyoichiro Saitoh. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kozo Tomatsu's work in the field of antifungal antibiotics represents a significant advancement in medical science. His innovative contributions continue to pave the way for new treatments and therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.